BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
The most effective method to Move toward Compensation Conversations for Cutting edge Practice Enrolled Attendants - 2Israel's haredi draft crisis: Court ruling and political stalemate reach breaking point
- 3Figure out How to Explore Land Close to 5G Pinnacles
- 4Fiber is something most people could use more of. But experts advise caution with 'fibermaxxing'
- 5A definitive Burger Confrontation: Which One Rules?
- Iran plans new restrictions in overhaul of Strait of Hormuz rules
- Doctor's orders? ‘Belly laugh at least two to five days a week'
- Vote in favor of your Favored kind of craftsmanship
- Apollo's impatient old-timers are rooting for NASA's return to the moon with Artemis II launch
- Ukrainian troops showed 'greater tactical imagination' than Western trainers, British officer says, pointing to their ambush tactics
- Trying to improve your health and wellness in 2026? Keep it simple
- NASA's Artemis 2 moon launch seen from space | Space photo of the day for April 2, 2026
- Nature's Best: A Manual for Beautiful Train Rides
- Strength training is crucial after menopause. How to make the most of your workouts
